From 230 vaccine candidates, seven COVID-19 vaccines are being used in at least one country, three of which have been de...
The European Union has announced an additional $600M for the COVAX Facility, doubling its contribution to date for the g...
Novavax, Inc, a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Biosci...
Gavi, the Vaccine Alliance announced today that it had signed a memorandum of understanding (MoU) with Novavax that, com...
Singapore Ministry of Health (MOH) has announced that the first shipment of Moderna vaccines arrived in Singapore...
WHo at a media briefing on Feb 10, 2021, updated that globally around 128 million vaccine doses administered so far and ...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced two supp...
The first Australian Government-funded training modules for the COVID-19 vaccination workforce, including for immunisati...
Sinovac Biotech Ltd has announced that the China National Medical Products Administration (NMPA) has granted a condition...
While governments are ramping up vaccination programs, continued research into the effectiveness of the vaccines is impe...
The Australian Government has secured an additional 10 million doses of the Pfizer-BioNTech COVID 19 vaccine on the advi...
Merck and BioNTech are further expanding their strategic partnership. Merck, in close collaboration with BioNTech, will ...
Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, announced that it has officially filed f...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that the...
The Asian Development Bank (ADB) has allocated $25 million to help the Philippine government purchase vaccines for the c...
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced th...
GSK, PATH, and Bharat Biotech (BBIL) on Jan 27, 2021, announced the signing of a product transfer agreement for the mala...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, on Jan 31, 2021,&...
